Zhong Guo Ji Jin Bao·2025-09-03 13:51Core Viewpoint - FTSE Russell announced significant adjustments to the FTSE China A50 Index and other related indices, effective after the market close on September 19, 2025, with changes reflecting shifts in market capitalization and sector focus [1]. Group 1: Index Adjustments - The FTSE China A50 Index will include new stocks from the innovative drug and CPO sectors, such as BeiGene-U, Xinyi Technology, WuXi AppTec, and Zhongji Xuchuang, while removing traditional dividend stocks like China Nuclear Power, China Unicom, Guodian NARI, and Wanhua Chemical [1]. - The FTSE China A150 Index will add stocks including China Nuclear Power, China Unicom, Huahong Semiconductor, Guodian NARI, and others, while removing stocks like BeiGene-U and WuXi AppTec [5]. - The FTSE China A200 Index will incorporate Huahong Semiconductor and others, while excluding stocks such as Primacy Securities and others [5]. - The FTSE China A400 Index will add 34 stocks including Yipin Hong and Changfei Fiber, while removing 34 stocks including Antu Biology and Guangzhou Port [5]. Group 2: Stock Performance - Zhongji Xuchuang, which is set to be included in the A50 Index, has seen its stock price rise by 246.45% year-to-date, with a total market capitalization of 473.5 billion yuan [3]. - Xinyi Technology's stock price has increased nearly 350% year-to-date, with a market capitalization of 367.4 billion yuan [3]. - WuXi AppTec's stock price has risen over 100% year-to-date, with a market capitalization of 32.55 billion yuan [3]. - BeiGene-U's stock price has also increased over 100% year-to-date, with a market capitalization of 28.07 billion yuan [3]. - The stocks being removed from the index, such as China Nuclear Power and China Unicom, have experienced year-to-date declines of 14.55% and 2.14%, respectively, with market capitalizations of 180.2 billion yuan and 171.6 billion yuan [3].